Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 71401-71450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05599880
The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia
PHASE2Recruiting
29 participants
Started: Jul 7, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT06042998
A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer
NARecruiting
588 participants
Started: Jul 7, 2023 · Completed: Dec 30, 2027
2 conditions1 sponsor1 location
NCT06066450
Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis
N/ARecruiting
1,000 participants
Started: Jul 7, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06226636
Immediate Pressor Response to Oral Salt
NARecruiting
300 participants
Started: Jul 7, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05798403
Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder
NARecruiting
204 participants
Started: Jul 7, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05726227
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
PHASE3Active, not recruiting
210 participants
Started: Jul 7, 2023 · Completed: Dec 7, 2026
1 condition1 sponsor47 locations
NCT06200844
The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
PHASE3Active, not recruiting
5,800 participants
Started: Jul 7, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor16 locations
NCT05069688
Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
PHASE1Recruiting
20 participants
Started: Jul 7, 2023 · Completed: Mar 31, 2025
2 conditions3 sponsors1 location
NCT05635812
Brain and Eye Markers of Facial Expression Recognition and Disorders Associated with Autistic Symptoms
N/ARecruiting
120 participants
Started: Jul 6, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05927701
Self-perceived Health Status and Healthcare Consumption of Idiopathic Scoliosis Patients Treated More Than 20 Years Ago: How Much do Operated and Non-operated Patients Differ?
N/ARecruiting
100 participants
Started: Jul 6, 2023 · Completed: Jul 6, 2026
1 condition1 sponsor2 locations
NCT06198764
A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection
PHASE3Recruiting
80 participants
Started: Jul 6, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor32 locations
NCT06042673
Impact of Pomegranate Seed Oil on Postprandial Cardiovascular Disease Risk Markers
NARecruiting
15 participants
Started: Jul 6, 2023 · Completed: Jul 28, 2024
1 condition1 sponsor1 location
NCT05884255
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
PHASE3Recruiting
220 participants
Started: Jul 6, 2023 · Completed: Oct 31, 2030
1 condition1 sponsor1 location
NCT06058234
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
N/ARecruiting
8,680 participants
Started: Jul 6, 2023 · Completed: Jun 30, 2029
2 conditions1 sponsor1 location
NCT05700617
Cardiac Power Output in Cardiogenic Shock Patients
EARLY_PHASE1Recruiting
5 participants
Started: Jul 6, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06361459
Stop Smoking in Spine Surgery
NARecruiting
210 participants
Started: Jul 6, 2023 · Completed: Dec 31, 2026
1 condition5 sponsors1 location
NCT05853367
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
PHASE1Recruiting
178 participants
Started: Jul 6, 2023 · Completed: Feb 12, 2028
2 conditions1 sponsor25 locations
NCT05292833
Study on Adherence to a Mediterranean Diet in a Population of Patients With Type 2 Diabetes
N/ARecruiting
60 participants
Started: Jul 6, 2023 · Completed: Nov 6, 2024
1 condition1 sponsor3 locations
NCT05852938
A Study of Zigakibart in Adults With IgA Nephropathy
PHASE3Active, not recruiting
383 participants
Started: Jul 6, 2023 · Completed: Jun 7, 2028
2 conditions1 sponsor200 locations
NCT05884944
Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients
NARecruiting
20 participants
Started: Jul 6, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05777993
A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study
PHASE4Enrolling by invitation
6 participants
Started: Jul 6, 2023 · Completed: Aug 31, 2029
2 conditions1 sponsor4 locations
NCT05476913
GEKO Venous Thromboembolism Prevention Study
NARecruiting
1,200 participants
Started: Jul 6, 2023 · Completed: Jun 30, 2025
4 conditions6 sponsors18 locations
NCT05987345
Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer
NARecruiting
10 participants
Started: Jul 6, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT05902104
CGM-Assisted Management of PN
N/ARecruiting
10 participants
Started: Jul 6, 2023 · Completed: Aug 31, 2025
3 conditions2 sponsors1 location
NCT05986968
Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage
NARecruiting
200 participants
Started: Jul 6, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor5 locations
NCT05687110
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
PHASE1Recruiting
43 participants
Started: Jul 6, 2023 · Completed: Sep 1, 2026
2 conditions1 sponsor21 locations
NCT05933681
Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation
NAActive, not recruiting
160 participants
Started: Jul 6, 2023 · Completed: Oct 30, 2025
1 condition2 sponsors1 location
NCT06239259
Validity and Reliability of Thai Version Clinical Questionnaire for Diagnosis of Carpal Tunnel Syndrome
N/ARecruiting
80 participants
Started: Jul 6, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05985278
Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
EARLY_PHASE1Recruiting
10 participants
Started: Jul 6, 2023 · Completed: Jun 15, 2026
1 condition1 sponsor1 location
NCT05256472
A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma
PHASE2Active, not recruiting
70 participants
Started: Jul 6, 2023 · Completed: Jun 22, 2026
2 conditions1 sponsor1 location
NCT06175351
Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).
PHASE1/PHASE2Active, not recruiting
80 participants
Started: Jul 6, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor22 locations
NCT05823571
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
PHASE1Active, not recruiting
32 participants
Started: Jul 6, 2023 · Completed: Mar 31, 2030
8 conditions2 sponsors1 location
NCT06893861
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
N/ARecruiting
3,100 participants
Started: Jul 6, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05919056
Cardiovascular Risk Assessment and Dynamic Monitoring-based Prevention Trial
NARecruiting
22,032 participants
Started: Jul 6, 2023 · Completed: Jul 1, 2028
1 condition2 sponsors1 location
NCT05944627
Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis
PHASE1/PHASE2Not yet recruiting
68 participants
Started: Jul 6, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor0 locations
NCT05241262
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
PHASE1Recruiting
18 participants
Started: Jul 6, 2023 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT05329441
Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents With Depression
N/ARecruiting
160 participants
Started: Jul 6, 2023 · Completed: Apr 30, 2028
1 condition6 sponsors1 location
NCT05674656
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
PHASE1/PHASE2Recruiting
20 participants
Started: Jul 6, 2023 · Completed: May 3, 2028
1 condition2 sponsors8 locations
NCT06992245
Characterization of Placental Diffusion
NARecruiting
40 participants
Started: Jul 6, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05960721
Low-dose NOAC Versus GDMT After LAAO
NARecruiting
4,220 participants
Started: Jul 6, 2023 · Completed: Jul 30, 2028
1 condition1 sponsor1 location
NCT05985655
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
165 participants
Started: Jul 6, 2023 · Completed: May 31, 2028
7 conditions1 sponsor12 locations
NCT05127824
Autologous Dendritic Cell Vaccine in Kidney Cancer
PHASE2Recruiting
42 participants
Started: Jul 6, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05886374
A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors
PHASE1Recruiting
81 participants
Started: Jul 6, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06094127
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
N/ARecruiting
300 participants
Started: Jul 6, 2023 · Completed: Oct 1, 2034
2 conditions1 sponsor10 locations
NCT06371794
EXploring novEl Molecular Determinants of DRAvet Syndrome Phenotype Heterogeneity
NAEnrolling by invitation
16 participants
Started: Jul 6, 2023 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT05875623
Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults
NAActive, not recruiting
500 participants
Started: Jul 6, 2023 · Completed: Dec 30, 2025
5 conditions2 sponsors1 location
NCT05851365
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer
EARLY_PHASE1Active, not recruiting
1 participants
Started: Jul 6, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT06081582
Toripalimab in Combined With Cetuximab,Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC
PHASE2Recruiting
33 participants
Started: Jul 6, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT06324136
Validation, Implementation, and Cost-analysis of a Strategy for Personalized Diagnosis of Rare Kidney Diseases
NARecruiting
300 participants
Started: Jul 6, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor3 locations
NCT06780735
Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative Chemotherapy
NARecruiting
128 participants
Started: Jul 6, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location